Skip to content

The efficacy of different antiemetic drugs combined on postoperative nausea and vomiting in gynecologic laparoscopic surgery

The efficacy of different antiemetic drugs combined on postoperative nausea and vomiting in gynecologic laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118240
Enrollment
Unknown
Registered
2026-02-03
Start date
2026-02-10
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Nausea and Vomiting

Interventions

Group A (dexamethasone + ondansetron):None
Group B (Dexamethasone + Fluphenazine):None
Group C (Dexamethasone + Pethidine Hydrochloride):None

Sponsors

The Affiliated Hospital of Jining Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–65 years; 2. Patients scheduled for gynecological laparoscopic surgery under general anesthesia (laparoscopic ovarian and/or fallopian tube surgery, hysterectomy and/or myomectomy, uterine lesion removal); 3. BMI 18.5–28 kg/m^2; 4. ASA classification I–II; 5. No history of drug allergies; 6. Patients and their families are informed and give consent, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe infection, severe heart failure, or liver and kidney dysfunction before surgery; 2. Use of antiemetic drugs, glucocorticoids, or psychiatric medications within 24 hours before surgery that are known to affect the occurrence of PONV; 3. History of chronic pain, long-term use of analgesics or psychiatric medications (including opioids, NSAIDs, and antidepressants); 4. History of radiotherapy or chemotherapy before surgery; 5. Diabetes; 6. Severe hearing impairment, language expression disorders, or mental illness, making patient unable to cooperate.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative nausea and vomiting;Postoperative nausea and vomiting severity;

Secondary

MeasureTime frame
Salvage antiemetics use;Restore quality Q15;The time of the first postoperative flatus;Incidence of adverse events;Postoperative pain score (at rest and when coughing and swallowing);

Countries

China

Contacts

Public ContactLi Yandong

The Affiliated Hospital of Jining Medical University

mzklyd@163.com+86 186 7876 6855

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026